Trinity Biotech (TRIB) Other Non-Current Liabilities (2022 - 2025)

Trinity Biotech has disclosed Other Non-Current Liabilities across 3 years of filings, most recently posting $781000.0 for Q4 2025.

• Other Non-Current Liabilities for Q4 2025 came in at $781000.0, up 941.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $781000.0 (up 941.33% YoY), and the FY2025 annual result was $781000.0, up 941.33% from the prior year.
• Other Non-Current Liabilities came in at $781000.0 for Q4 2025 at Trinity Biotech, down from $1.8 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $2.0 million in Q2 2022 to a low of $75000.0 in Q4 2024.
• The 3-year median for Other Non-Current Liabilities is $1.4 million (2024), against an average of $1.2 million.
• Peak annual rise in Other Non-Current Liabilities reached 941.33% in 2025, while the deepest fall reached 27.49% in 2025.
• Trinity Biotech's Other Non-Current Liabilities stood at $2.0 million in 2022, then plunged by 96.25% to $75000.0 in 2024, then surged by 941.33% to $781000.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at $781000.0 (Q4 2025), $1.8 million (Q2 2025), and $75000.0 (Q4 2024), per Business Quant data.